Development of a formulation of Pirodavir using 2-hydroxypropyl-β-cyclodextrin

被引：0
作者：
Jef Peeters
Peter Neeskens
Marcus Eli Brewster
机构：
[1] Johnson and Johnson,
[2] Chemical and Pharmaceutical Research,undefined
[3] Pharmaceutical Sciences,undefined
来源：
Journal of Inclusion Phenomena and Macrocyclic Chemistry | 2007年 / 57卷
关键词：
Pirodavir; Solubility; Cyclodextrins; Complexation capacity; Nasal formulation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Pirodavir, 4-[2-[1-(6-Methyl-3-pyridazinyl)-4-piperidinyl]ethoxy]benzoic acid ethyl ester, is an antiviral compound which has low aqueous solubility (<0.01 mg/ml). The compound is a weak base (pKa 5.8) with high lipophicity (logP 4.44). Ionization of the compound increases the solubility in acidic medium to 2.3 mg/ml at pH 2.4. However, a low pH is not acceptable for nasal application as this would induce irritation.
引用
收藏
页码：137 / 139
页数：2
相关论文
共 11 条
  • [1] Loftsson T.(1966)Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization J. Pharm. Sci. 85 1017-1025
  • [2] Brewster M.(1970)Binding specificity between small organic solutes in aqueous solution: Classification of some solutes into two groups according to binding tendencies J. Pharm. Sci 59 1601-1608
  • [3] Higuchi T.(1999)Cyclodextrins in nasal drug delivery Adv. Drug Del. Rev 36 41-57
  • [4] Kristiansen H.(undefined)undefined undefined undefined undefined-undefined
  • [5] Merkus F.W.H.M.(undefined)undefined undefined undefined undefined-undefined
  • [6] Verhoef J.C.(undefined)undefined undefined undefined undefined-undefined
  • [7] Marttin E.(undefined)undefined undefined undefined undefined-undefined
  • [8] Romeijn S.G.(undefined)undefined undefined undefined undefined-undefined
  • [9] van der Kuy P.H.M.(undefined)undefined undefined undefined undefined-undefined
  • [10] Hermens W.A.J.J.(undefined)undefined undefined undefined undefined-undefined
12